One Year Exenatide Therapy, Compared with Insulin Glargine, Reduces Postprandial Oxidative Stress in Metformin-Treated Patients with Type 2 Diabetes

M.C.M. Bunck, A. Corner, B. Eliasson, Y.B. Wu, R.M. Shaginian, P. Yan, R.J. Heine, U. Smith, H. Yki-Jarvinen, M.R. Taskinen, M. Diamant

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)A147-A147
JournalDiabetes
Volume58
Publication statusPublished - 2009

Cite this

Bunck, M. C. M., Corner, A., Eliasson, B., Wu, Y. B., Shaginian, R. M., Yan, P., ... Diamant, M. (2009). One Year Exenatide Therapy, Compared with Insulin Glargine, Reduces Postprandial Oxidative Stress in Metformin-Treated Patients with Type 2 Diabetes. Diabetes, 58, A147-A147.